Merz's Ultherapy PRIME received FDA 510(k) clearance for treatment of skin laxity on the knees, marking the first regulatory approval for any device in this indication. The clearance expands the addressable market for microfocused ultrasound beyond the face and neck, where Ultherapy has dominated since its original 2009 clearance.